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Pulmonary  tumor  thrombotic  microangiopathy  is  a  rare form  of  pulmonary  tumor  embolism  clinically
indistinguishable  from  pulmonary  thromboembolic  disease.  It is characterized  by ﬁbrocellular  intimal
proliferation  of small  pulmonary  arteries  and  arterioles  in patients  with  intraluminal  tumor  embolization.
We  report  the  case  of a 67-year-old  Caucasian  woman  who  had  been  treated  for  breast  cancer  5  years
prior  to  presentation  and  had  been  free  of recurrence  on  routine  clinical  surveillance.  She  was  admitted
for  evaluation  of  three  witnessed  syncopal  events  accompanied  by  tachypnea  and  hypotension.  Transtho-
racic  echocardiography  revealed  severe  right  ventricular  dilatation  and  severely  reduced  right ventricular
function.  Shortly  after  admission,  the  patient  became  acutely  unresponsive  and  expired  despite  aggres-
sive  resuscitation  measures.  The  proximate  cause  of death  was  a rupture  of  the  right ventricular  free
wall  and  a large  hemopericardium.  Histopathology  revealed  extensive  microscopic  occlusions  of  small
pulmonary  arteries  and arterioles  by metastatic  breast  carcinoma  with  superimposed  acute  thrombi.  Pul-
monary  tumor  thrombotic  microangiopathy  should  be  included  in  the  differential  diagnosis  of  patients
presenting  with  symptoms  of  pulmonary  thromboembolism  and  a history  of  malignancy.
<Learning objective:  Pulmonary  tumor  thrombotic  microangiopathy  is  a  rare form  of pulmonary  tumor
embolism  clinically  indistinguishable  from  pulmonary  thromboembolic  disease.  It is characterized  by
ﬁbrocellular  intimal  proliferation  of  small  pulmonary  arteries  and  arterioles  in  patients  with  intraluminal
tumor  embolization.  The  disease  has a  fulminant  course  and  poor  prognosis.  It  should  be  included  in
the  differential  diagnosis  of patients  presenting  with  symptoms  of pulmonary  thromboembolism  and  a
history  of malignancy.>
©  2014  Japanese  College  of  Cardiology.  Published  by Elsevier  Ltd.  All  rights  reserved.ntroduction
Pulmonary tumor thrombotic microangiopathy (PTTM) is a rare
orm of pulmonary tumor embolism. It is typically associated with
n underlying malignancy and is rarely diagnosed antemortem.
e report an exceedingly rare case of PTTM causing right ven-
ricular (RV) infarction, RV free wall rupture, and ensuing fatal
emopericardium.∗ Corresponding author at: Division of Cardiology, University of Minnesota Med-
cal Center, 420 Delaware Street SE, Minneapolis, MN 55455, USA.
el.: +1 612 625 7924; fax: +1 612 624 4411.
E-mail address: misso001@umn.edu (E. Missov).
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878-5409/© 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reCase report
A  67-year-old Caucasian woman  presented with the acute onset
of shortness of breath, chest pain, and three witnessed syncopal
events the day prior to admission. Her past medical history was
signiﬁcant for breast cancer treated with resection and chemother-
apy. She had been free of tumor recurrence at 5-year follow-up.
Information regarding receptor status, type of chemotherapy,
and adjuvant radiotherapy was  not available at the time of
admission. On presentation, she was tachypneic, hypotensive,
and hypoxemic. The electrocardiogram showed sinus tachycar-
dia, right axis deviation, and negative T-waves in the inferior
and lateral leads. The electrocardiographic S1Q3 pattern classically
described in acute pulmonary embolism was  not present. Car-
diac troponin I was  marginally elevated at 0.11 ng/mL (reference
range, <0.04 ng/mL). The chest radiograph showed no clear pathol-
ogy. Transthoracic echocardiography demonstrated RV dilatation
served.
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nd severely decreased RV function. Empiric treatment with intra-
enous heparin was initiated given the high clinical suspicion for
cute pulmonary thromboembolism. A contrasted computerized
omography study of the chest and a ventilation–perfusion scan
ere obtained after initial hemodynamic stabilization. Both stud-
es were unremarkable. A few hours later, the patient became
cutely unresponsive and expired despite aggressive resuscita-
ion measures, including mechanical ventilation, pharmacological
nd electrical cardioversion of atrial ﬁbrillation with rapid ven-
ricular response, vasopressor support, and large volume ﬂuid
esuscitation. Echocardiographic imaging was not available during
ardiopulmonary resuscitation.
Autopsy identiﬁed a rupture of the anterior RV wall causing a
arge hemopericardium as the proximate cause of death (Fig. 1A).
he coronary arteries showed no occlusive or thrombotic lesions.
icroscopic sections near the site of rupture demonstrated hyper-
osinophilic shrunken cardiomyocytes with a mild inﬂammatory
nﬁltrate and intracellular edema, indicative of an acute myocar-
ial infarction (Fig. 1B). No large pulmonary emboli were identiﬁed
n gross examination of the lungs. However, the pulmonary vas-
ulature demonstrated extensive microscopic occlusion of small
rteries and arterioles by metastatic breast carcinoma (conﬁrmed
y immunostaining) in association with acute ﬁbrin thrombi. There
ere widespread chronic vascular changes including intimal and
edial proliferation, ﬁbrosis, and recanalization in association witharcinoma cells, suggesting a subacute accumulation of tumor
mboli prior to the current presentation (Fig. 1C and D). A reser-
oir of carcinoma was identiﬁed in the bone marrow and in several
eri-aortic lymph nodes completely effaced by tumor cells.
ig. 1. Gross pathology and histopathology. (A) Dilated right ventricle with rupture of 
yoﬁbers, edema, and mild interstitial inﬂammation (original magniﬁcation 200×). (C) P
ith  superimposed acute ﬁbrin thrombi (original magniﬁcation 100×). (D) Myxoid ﬁbrosi
rteriole (original magniﬁcation 200×). All stains are hematoxylin–eosin.logy Cases 9 (2014) 230–232 231
Discussion
PTTM is a rare clinicopathological form of pulmonary tumor
embolism with fulminant clinical course, no effective treatment,
and poor prognosis [1–3]. It is clinically indistinguishable from pul-
monary thromboembolism and is usually diagnosed postmortem.
It is found in 0.9–3.3% of autopsies of patients with adenocarcino-
mas of the breast, stomach, liver, colon, and lung. Histologically, it is
characterized by concentric ﬁbrocellular intimal and medial prolif-
eration of small pulmonary arteries and arterioles with associated
thrombus formation. The proliferative process of smooth muscle
cells and ﬁbroblasts is triggered by the activation of the coagulation
cascade in the pulmonary vasculature and the release of inﬂamma-
tory mediators and growth factors, including endothelial growth
factor, platelet-derived growth factor, and pleiotropic cytokines
[4]. Clinically, acute or sub-acute cor pulmonale, sudden cardiovas-
cular collapse, pulmonary hypertension, and increased pulmonary
vascular resistance are manifestations of the disease.
RV infarction is known to occur in the acute phase of large
pulmonary thromboembolism in the absence of obstructive coro-
nary lesion or thrombosis [5]. Pathophysiologically, low cardiac
output, hypoxemia, systemic hypotension, and increased RV after-
load result in decreased coronary perfusion pressure and increased
myocardial oxygen consumption. These factors likely led to RV
subendocardial ischemia and infarction with subsequent rupture
of the RV free wall despite the lack of signiﬁcant obstructive coro-
nary lesions in the presented case. We also carefully considered
whether cardiopulmonary resuscitation might have contributed to
RV rupture and hemopericardium. The sternal plate was carefully
the anterior right ventricular wall. (B) Myocardial infarct with hypereosinophilic
ulmonary arterial recanalization in response to chronic occlusion by tumor emboli
s and intimal–medial proliferative response to adherent tumor cells in a pulmonary
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xamined at autopsy. Particular attention was focused on the
ntegrity of the sternum and articulating ribs for signs of fracture
nd internal organ damage. The sternal plate was found to be intact
nd free of fractures. Furthermore, there was no laceration of the
ericardium or contusion of any other cardiac structure or of the left
ung parenchyma; there was no hemothorax, leading us to believe
hat the extensive burden of PTTM resulted in RV infarction and
upture of the RV free wall with ensuing hemopericardium.
onclusions
PTTM is an under-recognized clinical entity that should be
onsidered in patients with a history of malignancy and symp-
oms suggestive of pulmonary embolism, provided that pulmonary
hromboembolic disease has been excluded. The diagnosis of PTTM
as implications for treatment options, prognosis, and outcome.
[logy Cases 9 (2014) 230–232
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